Cargando…

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia

Immunoglobulin (Ig) replacement therapy dramatically changed the clinical course of primary hypogammaglobulinemias, significantly reducing the incidence of infectious events. Over the last two decades its use has been extended to secondary antibody deficiencies, particularly those related to hematol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Compagno, Nicolò, Malipiero, Giacomo, Cinetto, Francesco, Agostini, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259107/ https://www.ncbi.nlm.nih.gov/pubmed/25538710 http://dx.doi.org/10.3389/fimmu.2014.00626

Ejemplares similares

Rituximab in refractory sarcoidosis: a single centre experience
por: Cinetto, Francesco, et al.
Publicado: (2015)

Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
por: Noto, Alessandro, et al.
Publicado: (2023)

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
por: Ohmoto, Akihiro, et al.
Publicado: (2022)

Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study
por: Scarpa, Riccardo, et al.
Publicado: (2022)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2021)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk
por: Wo, Stephanie, et al.
Publicado: (2022)

Mild Hypogammaglobulinemia Can Be a Serious Condition
por: Janssen, Lisanne M. A., et al.
Publicado: (2018)

Does Intravenous Immunoglobulin Therapy Prolong Immunodeficiency in Transient Hypogammaglobulinemia of Infancy?
por: Memmedova, Lale, et al.
Publicado: (2013)

4396 Immunoglobulin administration and hypogammaglobulinemia during pediatric acute leukemia therapy
por: Edington, Holly, et al.
Publicado: (2020)

Real-World Experiences With Facilitated Subcutaneous Immunoglobulin Substitution in Patients With Hypogammaglobulinemia, Using a Three-Step Ramp-Up Schedule
por: Hustad, Nina B., et al.
Publicado: (2021)

P1516: THE CLINICAL IMPACT OF IMMUNOGLOBULIN REPLACEMENT THERAPY ON SEVERE BACTERIAL INFECTION IN PATIENTS WITH HYPOGAMMAGLOBULINEMIA SECONDARY TO HEMATOLOGIC MALIGNANCIES: A JAPANESE CLAIMS DATABASE STUDY
por: Mihara, Keichiro, et al.
Publicado: (2023)

Lifelong immunoglobulin replacement is not always necessary: A case description of a patient with recurrent infections and hypogammaglobulinemia
por: Napiorkowska-Baran, Katarzyna, et al.
Publicado: (2019)

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia
por: Barmettler, Sara, et al.
Publicado: (2018)

Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype
por: Scarpa, Riccardo, et al.
Publicado: (2020)

Primary Immune Deficiency: Patients’ Preferences for Replacement Immunoglobulin Therapy
por: Gonzalez, Juan Marcos, et al.
Publicado: (2022)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
por: Wågström, Per, et al.
Publicado: (2022)

Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report
por: Zhang, Weihe, et al.
Publicado: (2022)

Diagnostic Immunization with Bacteriophage ΦX 174 in Patients with Common Variable Immunodeficiency/Hypogammaglobulinemia
por: Smith, Lauren L., et al.
Publicado: (2014)

Intravenous Immunoglobulin for Hypogammaglobulinemia after Lung Transplantation: A Randomized Crossover Trial
por: Lederer, David J., et al.
Publicado: (2014)

Hypogammaglobulinemia secondary to B-cell depleting therapies in neuroimmunology: Comparing management strategies
por: Kelly, Hannah, et al.
Publicado: (2023)

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
por: Poto, Remo, et al.
Publicado: (2023)

Hypogammaglobulinemia due to CAR T-cell therapy
por: Doan, Andrew, et al.
Publicado: (2017)

CXCL12 Mediates Aberrant Costimulation of B Lymphocytes in Warts, Hypogammaglobulinemia, Infections, Myelokathexis Immunodeficiency
por: Roselli, Giuliana, et al.
Publicado: (2017)

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT
por: Luterbacher, Fanny, et al.
Publicado: (2021)

Hypogammaglobulinemia with Facial Edema
por: Knight, Adina Kay, et al.
Publicado: (2006)

Rituximab Use and Hypogammaglobulinemia
por: Alhassan, Eaman, et al.
Publicado: (2020)

What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review
por: Jones, Georgina L., et al.
Publicado: (2018)

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)

Cytomegalovirus Colitis in Primary Hypogammaglobulinemia With Normal CD4+ T Cells: Deficiency of CMV-Specific CD8+ T Cells
por: Agrawal, Sudhanshu, et al.
Publicado: (2019)

The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID)
por: Ameratunga, Rohan, et al.
Publicado: (2019)

Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
por: Besada, Emilio
Publicado: (2016)

Transient hypogammaglobulinemia and severe atopic dermatitis: Open-label treatment with immunoglobulin in a case series
por: Breslin, Moira E., et al.
Publicado: (2016)

Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
por: Farhat, Lara, et al.
Publicado: (2018)

M410 COVID-19 INFECTION IN A PATIENT WITH SECONDARY HYPOGAMMAGLOBULINEMIA
por: Maghen, D., et al.
Publicado: (2020)

Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency
por: Pulvirenti, Federica, et al.
Publicado: (2018)

Tonsillar granuloma associated with hypogammaglobulinemia
por: Laajala, Aleksi, et al.
Publicado: (2020)

Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia
por: Mims, Martha P.
Publicado: (2018)

COVID-19, plasma, and hypogammaglobulinemia
por: Murphy, Michael F., et al.
Publicado: (2020)

Adverse Effects of Immunoglobulin Therapy
por: Guo, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g2g78n5h3tmer4vhdm868i8ota